Title |
Angiographic Efficacy of the Atriclip Left Atrial Appendage Exclusion Device Placed by Minimally Invasive Thoracoscopic Approach
|
---|---|
Published in |
JACC: Clinical Electrophysiology, May 2017
|
DOI | 10.1016/j.jacep.2017.03.008 |
Pubmed ID | |
Authors |
Christopher R. Ellis, Sam G. Aznaurov, Neel J. Patel, Jennifer R. Williams, Kim Lori Sandler, Steven J. Hoff, Stephen K. Ball, S. Patrick Whalen, John Jeffrey Carr |
Abstract |
This study sought to assess long-term left atrial appendage (LAA) closure efficacy of the Atriclip applied via totally thoracoscopic (TT) approach with computed tomographic angiography. LAA closure is associated with a low risk for atrial fibrillation-related embolic stroke. The Atriclip exclusion device allows epicardial LAA closure, avoiding the need for post-operative oral anticoagulation. Previous data with Atriclip during open chest procedures show a high efficacy rate of closure >95%. Three-dimensional volumetric 2-phase computed tomographic angiography ≥90 days post-implantation was independently assessed by chest radiology for complete LAA closure on all consented subjects identified retrospectively as having had a TT-placed Atriclip at Vanderbilt University Medical Center from June 13, 2011, to October 6, 2015. Complete LAA closure (defined by complete exclusion of the LAA with no exposed trabeculations, and clip within 1 cm from the left circumflex artery) was found in 61 of 65 subjects (93.9%). Four cases had incomplete closure (6.2%). Two clips were placed too distally, leaving a large stump with exposed trabeculae. Two clips failed to address a secondary LAA lobe. No major complications were associated with TT placement of the Atriclip. Follow-up over 183 patient-years revealed 1 stroke in a patient with complete LAA closure and no thrombus (hypertensive cerebrovascular accident). Angiographic LAA closure efficacy with a TT-placed Atriclip is high (93.9%). The clinical significance of a remnant stump is unknown. Confirmation of complete LAA occlusion should be made before cessation of systemic anticoagulation. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 9 | 17% |
Spain | 6 | 11% |
France | 4 | 8% |
Mexico | 4 | 8% |
Australia | 2 | 4% |
Ecuador | 2 | 4% |
Chile | 1 | 2% |
Netherlands | 1 | 2% |
Brazil | 1 | 2% |
Other | 5 | 9% |
Unknown | 18 | 34% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 35 | 66% |
Practitioners (doctors, other healthcare professionals) | 15 | 28% |
Scientists | 2 | 4% |
Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 54 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 13% |
Student > Master | 6 | 11% |
Student > Bachelor | 6 | 11% |
Student > Doctoral Student | 5 | 9% |
Student > Ph. D. Student | 5 | 9% |
Other | 11 | 20% |
Unknown | 14 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 30 | 56% |
Unspecified | 3 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Engineering | 1 | 2% |
Unknown | 19 | 35% |